NCT01572870 Duplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF Patients Status COMPLETED Phase N/A
NCT01572194 Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation (MUCO-IRC) Status TERMINATED Phase NA
NCT01548729 Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT01543620 Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis Status UNKNOWN Phase N/A
NCT01543191 A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT01537666 Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics Status COMPLETED Phase PHASE1
NCT01537614 Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT01533636 CF And Effects of Drugs Mixed Ex Vivo With Sputum for Mucolytic Treatment Status COMPLETED Phase N/A
NCT01531673 Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation Status COMPLETED Phase PHASE2
NCT01521338 G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) Status COMPLETED Phase N/A
NCT01509339 Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis Status WITHDRAWN Phase PHASE1
NCT01494909 Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function Status COMPLETED Phase NA
NCT01479166 Bronchial Inflammation of Small Airways in Patients With Cystic Fibrosis Status COMPLETED Phase N/A